|Bid||87.67 x 800|
|Ask||87.68 x 800|
|Day's Range||86.02 - 87.80|
|52 Week Range||71.50 - 95.72|
|Beta (5Y Monthly)||0.34|
|PE Ratio (TTM)||13.40|
|Earnings Date||Oct 27, 2022|
|Forward Dividend & Yield||2.76 (3.20%)|
|Ex-Dividend Date||Sep 14, 2022|
|1y Target Est||100.90|
Subscribe to Yahoo Finance Plus to view Fair Value for MRK
In this article, we discuss 10 best diversified dividend stocks to buy now. You can skip our detailed analysis of best dividend stocks and their returns over the years, and go directly to read 5 Best Diversified Dividend Stocks to Buy Now. In September, the S&P 500 reported its largest percentage drop in 20 years, […]
Bristol Myers (BMY) expects recent drug approvals to generate an incremental stream of revenues and combat competition for its key drugs.
There wouldn't be many who think Merck & Co., Inc.'s ( NYSE:MRK ) price-to-earnings (or "P/E") ratio of 13.1x is worth...